The market sentiment towards QuidelOrtho Corporation has been negative, reflected in the declining share price. The company's poor performance over the past few years has resulted in a total loss of 5% per year over five years for shareholders.

QuidelOrtho's low P/S ratio is a result of its disappointing revenue forecast. Poor revenue performance and below-average growth predictions have dampened investor sentiment and share price.

J.P. Morgan and William Blair analysts downgraded the stock due to unclear outlook for adj. EPS and core margins. The company's shares are expected to remain under pressure until management improves execution and margins.

QuidelOrtho's current P/S ratio is typical for a company with limited growth expectations. Weak revenue growth outlook seems to suppress the stock's P/S ratio with no anticipated improvement to justify a higher P/S ratio.

Investor confidence hints at potential long-term improvement despite share price decline, but last year's performance and long-term share price weakness spell potential issues, drawing contrarian investors anticipating a turnaround.